Status:
WITHDRAWN
Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By Cancer
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Anorexia
Constipation, Impaction, and Bowel Obstruction
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
RATIONALE: The use of a nicotine inhaler may help decrease appetite and relieve "hunger pain" (an intense craving for food) in patients with malignant bowel obstruction caused by cancer. PURPOSE: Thi...
Detailed Description
OBJECTIVES: * Determine whether patients with malignant bowel obstruction due to incurable cancer utilize a potential therapy for "hunger pain." * Determine, preliminarily, the efficacy and toxicity ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of any incurable malignancy
- Presence of malignant bowel obstruction
- Must be on strict "nothing per os" (NPO) status over the next 48 hours
- Ice chips allowed
- Acknowledges that "hunger pain" is a problem
- PATIENT CHARACTERISTICS:
- Mentally competent
- No history of life-threatening arrhythmia
- No severe or worsening angina
- No accelerated hypertension
- No known hypersensitivity to nicotine
- Not pregnant or nursing
- Negative pregnancy test
- PRIOR CONCURRENT THERAPY:
- Concurrent short-term use of dexamethasone or other hormonal therapy or symptom control strategy allowed
Exclusion
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00425906
Start Date
December 1 2003
Last Update
January 12 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.